Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia

Conditions:   Hypertension;   Hyperaldosteronaemia Interventions:   Drug: Spironolactone;   Drug: Finerenone;   Other: Blank control Sponsor:   Nanfang Li Not yet recruiting

Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials